September 25, 2024 | 11:08
Vietnam healthcare market size is estimated to reach $23.7 billion and grow at an average rate of 7.5 per cent annually from 2023 to 2028. Healthcare expenditure per capita is also projected to increase from $237 to $328 in that time.
August 01, 2024 | 21:49
Vietnam has among the highest pharmaceutical industry growth rates worldwide.
July 31, 2024 | 16:19
While continuing to make positive business results in Vietnam’s pharma market in the first half of 2024, multinationals are seeking an expansion of their rights.
July 24, 2023 | 08:00
As countries are in the race to latch onto new investment from the innovative pharma industry, Vietnam is being urged to improve its legal system to increase its competitiveness.
December 07, 2022 | 14:00
More international pharma and medical device businesses are rushing to venture further in Vietnam, anticipating wide growth potential.
December 01, 2022 | 13:00
Multinational corporations in Vietnam are expecting changes in drug rules to make more business and investment progress. Tran Ngoc Anh, representative of the US-ASEAN Business Council, discussed with VIR’s Bich Thuy the current barriers and expectations stemming from legal adjustments.
October 11, 2021 | 16:27
While a number of foreign companies have moved part of their production or orders to other countries, many still see Vietnam as a good location for investment in the long term.
July 12, 2021 | 13:00
While Vietnam has witnessed positive developments in the pharmaceutical and healthcare spheres over the past few years, some issues still need to be ironed out.
February 24, 2020 | 14:00
As Vietnam has become an emerging pharmaceutical market, Imexpharm is eager to invest in innovation and technology to capitalise on rising healthcare demand.
August 21, 2019 | 10:06
Permitting foreign-invested enterprises to conduct direct imports, Vietnam’s pharmaceutical policies are now more in alignment with international treaties.
July 18, 2018 | 11:42
Growing participation of foreign players in Vietnam’s pharmaceutical market is putting pressures on local pharmaceutical firms, however analysts suggest the deals with foreign partners could bring certain benefits to their local partners.